Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD - PubMed (original) (raw)

Review

Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD

Lorraine V Kalia et al. Nat Rev Neurol. 2016 Feb.

No abstract available

PubMed Disclaimer

Similar articles

• Parkinson disease: Peripheral α-synuclein deposits - prodromal markers for Parkinson disease?
  Wood H. Wood H. Nat Rev Neurol. 2016 May;12(5):249. doi: 10.1038/nrneurol.2016.54. Epub 2016 Apr 15. Nat Rev Neurol. 2016. PMID: 27080519 No abstract available.
• A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
  Jellinger KA. Jellinger KA. Biochim Biophys Acta. 2009 Jul;1792(7):730-40. doi: 10.1016/j.bbadis.2008.07.006. Epub 2008 Aug 5. Biochim Biophys Acta. 2009. PMID: 18718530 Review.
• Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
  Visanji NP, Marras C, Hazrati LN, Liu LW, Lang AE. Visanji NP, et al. Mov Disord. 2014 Apr;29(4):444-50. doi: 10.1002/mds.25789. Epub 2013 Dec 26. Mov Disord. 2014. PMID: 24375496 Review.
• [Disease-Modifying Therapy for Parkinson's Disease].
  Shimura H, Hattori N. Shimura H, et al. Brain Nerve. 2017 Feb;69(2):159-165. doi: 10.11477/mf.1416200656. Brain Nerve. 2017. PMID: 28202824 Review. Japanese.
• Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.
  Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Björklund T, Wang ZY, Roybon L, Melki R, Li JY. Holmqvist S, et al. Acta Neuropathol. 2014 Dec;128(6):805-20. doi: 10.1007/s00401-014-1343-6. Epub 2014 Oct 9. Acta Neuropathol. 2014. PMID: 25296989

Cited by

• Nuclear alpha-synuclein accelerates cell senescence and neurodegeneration.
  Du T, Li G, Zong Q, Luo H, Pan Y, Ma K. Du T, et al. Immun Ageing. 2024 Jul 12;21(1):47. doi: 10.1186/s12979-024-00429-0. Immun Ageing. 2024. PMID: 38997709 Free PMC article.
• Mitophagy in Parkinson's Disease: From Pathogenesis to Treatment.
  Liu J, Liu W, Li R, Yang H. Liu J, et al. Cells. 2019 Jul 12;8(7):712. doi: 10.3390/cells8070712. Cells. 2019. PMID: 31336937 Free PMC article. Review.
• Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease In Vitro and In Vivo.
  Zhou H, Shao M, Yang X, Li C, Cui G, Gao C, Di L, Zhong H, Wang Y, Zhang Z, Lee SM. Zhou H, et al. Oxid Med Cell Longev. 2019 Nov 14;2019:8169125. doi: 10.1155/2019/8169125. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31827703 Free PMC article.
• Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study.
  Zapała B, Stefura T, Wójcik-Pędziwiatr M, Kabut R, Bałajewicz-Nowak M, Milewicz T, Dudek A, Stój A, Rudzińska-Bar M. Zapała B, et al. J Clin Med. 2021 Dec 3;10(23):5698. doi: 10.3390/jcm10235698. J Clin Med. 2021. PMID: 34884399 Free PMC article.
• Excessive STAU1 condensate drives mTOR translation and autophagy dysfunction in neurodegeneration.
  Zhao R, Huang S, Li J, Gu A, Fu M, Hua W, Mao Y, Lei QY, Lu B, Wen W. Zhao R, et al. J Cell Biol. 2024 Aug 5;223(8):e202311127. doi: 10.1083/jcb.202311127. Epub 2024 Jun 24. J Cell Biol. 2024. PMID: 38913026 Free PMC article.

References

1. 1. Mov Disord. 2015 Oct;30(12):1600-11 - PubMed
2. 1. Nature. 2015 Jun 18;522(7556):340-4 - PubMed
3. 1. Brain. 2015 Jun;138(Pt 6):1642-57 - PubMed
4. 1. Lancet. 2015 Aug 29;386(9996):896-912 - PubMed
5. 1. Lancet Neurol. 2015 Jan;14 (1):57-64 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information